In a significant move for healthcare innovation, Oracle has announced a collaborative agreement with AstraZeneca aimed at harnessing artificial intelligence (AI) and real-world data to enhance the identification of eligible patients for clinical trials. This partnership is set to leverage AstraZeneca's extensive scientific and therapeutic knowledge, combined with Oracle's robust capabilities in health data, cloud computing, AI, analytics, and clinical workflow.
Under this non-binding agreement, the two companies plan to investigate specific use cases designed to streamline the clinical trial process. By employing cutting-edge applications and AI, they aim to help healthcare teams identify potential trial candidates more efficiently, ultimately improving patient accessibility to crucial clinical trials and addressing one of the major challenges in this field—patient recruitment. Initial areas of focus may encompass oncology, cardiovascular and metabolic diseases, respiratory conditions, immunology, and rare diseases.
Pascal Soriot, CEO of AstraZeneca, emphasized the significance of this collaboration, stating, “This partnership merges leaders in healthcare and AI on a global scale to fast-track the transition from medical discovery to patient care. By fusing AstraZeneca’s exceptional scientific prowess with Oracle’s extensive data and technological tools, we can help healthcare professionals identify patients more promptly, optimize clinical trials, and facilitate ongoing evidence generation throughout a drug's lifecycle.”
Mike Sicilia, Oracle's CEO, highlighted the immense potential for AI within the healthcare sector, noting that improved data utilization can transform scientific advances into tangible patient benefits. He expressed optimism that this union of AstraZeneca's scientific strengths and Oracle's data and AI capabilities will expedite research, increase patient enrollment in clinical trials, and expedite the integration of relevant insights into clinical practices.
AstraZeneca's Chief Digital, Data, and AI Officer, Anne-Claire Gerbaldi, remarked on the pressing need to improve patient care pathways, acknowledging that many patients experience delays in diagnoses or face lengthy journeys to receive needed treatments. Gerbaldi stated that their goal is to utilize AI to link insights from scientific research, clinical trials, and routine medical care. This approach aims to generate data that enhances research, fosters innovation, and ultimately improves patient outcomes. She expressed confidence that the synergy between AstraZeneca and Oracle can lead to more effective clinical trials and ensure timely diagnoses.
Seema Verma, Oracle’s executive vice president and general manager for Health and Life Sciences, pointed out that advancements in healthcare hinge on bridging the gap between scientific knowledge and everyday clinical decisions. She conveyed that AstraZeneca's expertise, combined with Oracle's secure data infrastructure and advanced capabilities, could help healthcare systems more swiftly identify eligible patients, promote access to clinical trials, and generate supportive evidence for informed decision-making within health systems.
Looking ahead, both companies plan to explore a continuous learning model that integrates findings from clinical research and routine care to enhance future study designs, safety protocols, and overall patient care. They anticipate establishing shared governance, reusable technology components, and standardized outcome measures to evaluate effectiveness and determine if successful strategies can be applied across different diseases and geographical locations.
For further inquiries, please contact Kris Reeves at Oracle Corporate Communications via email at [email protected].
About Oracle: Oracle delivers comprehensive application suites coupled with secure and autonomous infrastructure within the Oracle Cloud ecosystem. To learn more about Oracle (NYSE: ORCL), visit www.oracle.com.
Trademarks: Oracle, Java, MySQL, and NetSuite are registered trademarks of Oracle Corporation. NetSuite pioneered the cloud computing era.
